| |
Group 1
|
Group 1
| |
Group 2
|
Group 2
| |
Group 3
|
Group 3
| |
|---|
|
Pre
|
Post
| |
Pre
|
Post
| |
Pre
|
Post
| |
|---|
|
N = 57
|
N = 57
|
p
|
N = 56
|
N = 56
|
p
|
N = 58
|
N = 58
|
p
|
|---|
|
Symptoms - VAS
|
|
Nasal obstruction
|
70.4(21.9)
|
29.1 (26.6)
|
0.01
|
71.8 (16.4)
|
27.5 (22.5)
|
0.01
|
66.8 (23.6)
|
37.2 (24.8)
|
0.01
|
|
Nasal discharge
|
40.6 (31.9)
|
20.5 (25.4)
|
0.01
|
39.8 (32.1)
|
24.2 (28.0)
|
0.01
|
42.0 (33.6)
|
29.5 (30.0)
|
0.02
|
|
Sneezing
|
32.2 (28.7)
|
18.6 (23.4)
|
0.01
|
27.8 (25.3)
|
13.2 (19.6)
|
0.01
|
26.4 (2540)
|
20.9 (20.9)
|
0.18
|
|
Snoring
|
50.3 (36.2)
|
22.2 (27.6)
|
0.01
|
53.2 (32.0)
|
27.4 (26.8)
|
0.01
|
45.8 (36.3)
|
32.7 (30.0)
|
0.01
|
|
Oral breathing
|
67.2 (28.5)
|
26.3 (29.7)
|
0.01
|
58.7 (30.8)
|
22.7 (25.9)
|
0.01
|
51.9 (31.9)
|
31.9 (30.5)
|
0.01
|
|
Reduced general health
|
47.7 (33.8)
|
14.1 (22.0)
|
0.01
|
43.4 (28.9)
|
13.0 (20.5)
|
0.01
|
40.4 (31.5)
|
18.4 (23.2)
|
0.01
|
|
HQOL - SNOT - 20
|
|
Total SNOT 20
|
1.58 (0.78)
|
0.97 (0.80)
|
0.01
|
1.70 (0.84)
|
0.93 (0.71)
|
0.01
|
1.59 (0.83)
|
1.15 (0.87)
|
0.01
|
|
Subset:
|
|
Rhinologic
|
1.83 (0.97)
|
1.18 (0.82)
|
0.01
|
1.82 (1.05)
|
1.17 (0.85)
|
0.01
|
1.84 (0.94)
|
1.44 (1.06)
|
0.01
|
|
Ear/facial
|
0.75 (0.75)
|
0.47 (0.67)
|
0.01
|
1.05 (0.91)
|
0.50 (0.58)
|
0.01
|
1.10 (0.86)
|
0.79 (0.92)
|
0.01
|
|
Sleep
|
2.25 (1.33)
|
1.33 (1.28)
|
0.01
|
2.23 (1.31)
|
1.15 (1.20)
|
0.01
|
2.01 (1.46)
|
1.43 (1.38)
|
0.01
|
|
Psychological
|
1.45 (1.16)
|
0.82 (1.10)
|
0.01
|
1.68 (1.07)
|
0.81 (0.93)
|
0.01
|
1.39 (1.04)
|
0.90 (1.03)
|
0.01
|
|
HQOL - SF- 36
|
|
PF physical functioning
|
89.5 (9.89)
|
91.6 (12.3)
|
0.02
|
83.6 (15.2)
|
88.1 (19.3)
|
0.01
|
84.5 (16.9)
|
87.7 (18.9)
|
0.14
|
|
RP role-physical
|
68.3 (22.2)
|
75.2 (20.5)
|
0.01
|
61.6 (28.8)
|
71.2 (24.4)
|
0.01
|
69.3 (22.3)
|
72.2 (25.0)
|
0.26
|
|
BP bodily pain
|
71.5 (26.0)
|
76.9 (26.1)
|
0.03
|
66.0 (30.2)
|
71.8 (29.0)
|
0.13
|
68.5 (26.7)
|
72.7 (26.3)
|
0.35
|
|
GH general health
|
69.7 (21.3)
|
73.6 (23.8)
|
0.07
|
62.4 (22.5)
|
67.4 (23.8)
|
0.02
|
59.5 (23.1)
|
64.6 (23.5)
|
0.03
|
|
VT vitality
|
48.7 (19.4)
|
53.8 (18.5)
|
0.02
|
44.4 (15.6)
|
52.1 (16.0)
|
0.01
|
46.1 (18.4)
|
54.3 (19.8)
|
0.01
|
|
SF social functioning
|
80.5 (23.3)
|
86.2 (20.8)
|
0.01
|
76.8 (23.9)
|
80.4 (23.9)
|
0.20
|
80.2 (23.0)
|
85.6 (21.4)
|
0.09
|
|
RE role-emotional
|
85.7 (20.8)
|
90.8 (16.9)
|
0.08
|
81.8 (25.1)
|
84.3 (24.0)
|
0.16
|
91.4 (15.5)
|
91.4 (18.3)
|
0.55
|
|
MH general mental health
|
69.2 (12.9)
|
70.9 (14.4)
|
0.20
|
66.6 (11.3)
|
69.1 (12.0)
|
0.04
|
70.6 (10.3)
|
72.1 (11.0)
|
0.18
|
|
Physical health summary
|
74.9 (15.2)
|
79.3 (17.3)
|
0.01
|
68.5 (20.4)
|
74.6 (20.9)
|
0.01
|
70.5 (17.0)
|
74.3 (19.8)
|
0.05
|
|
Mental health summary
|
71.5 (16.7)
|
76.4 (17.3)
|
0.01
|
66.7 (17.2)
|
71.0 (18.4)
|
0.01
|
69.3 (15.1)
|
74.0 (17.1)
|
0.01
|
- Abbreviations: Group 1, septoplasty; Group 2, septoplasty combined with radiofrequency therapy of inferior turbinate (RFIT); Group 3, RFIT only; VAS, Visual Analog Scale; SNOT-20, Sino-Nasal-Outcome-Test-20; SF-36, Short-Form-Health-Survey-36; pre, preoperative; post, postoperative. Data are presented in mean with standard deviation, p-values ≤ 0.01 are considered significant
